Clearside Biomedical, Inc. to Report Fourth Quarter and

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
65
Clearside Biomedical, Inc. to Report Fourth Quarter and Full Year 2016 Financial Results on March 14, 2017 – Conference Call to Follow

ALPHARETTA, Ga., March 07, 2017 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (NASDAQ: CLSD ) (“Clearside” or the “Company”), a late-stage biopharmaceutical company developing first-in-class drug therapies to treat back-of-the-eye diseases, announced today that its fourth quarter and full year 2016 financial results will be released at 7:00 a.m. on Tuesday, March 14, 2017. Following the release, Clearside will host a live conference call and webcast at 8:30 a.m. ET to discuss the Company’s financial results and provide a general business and strategic review.

The live webcast and a replay may be accessed by visiting the “Investor Relations” section at www.clearsidebio.com . Alternately, please call (844) 263-8310 (U.S.) or (213) 358-0959 (international) to participate in the live conference call. The conference ID number for the live call is 84209729. Please dial in approximately 10 minutes prior to the call. An archive of the webcast will be available until April 13, 2017.

About Clearside Biomedical, Inc.

Clearside Biomedical, Inc., headquartered in Alpharetta, GA, is a late-stage clinical ophthalmic biopharmaceutical company that envisions a world without blindness. Clearside relentlessly pursues transformative, elegant, precise solutions to restore and preserve vision. Clearside is developing advanced clinical and pre-clinical candidates using a proprietary treatment approach offering unprecedented access to the back of the eye through the suprachoroidal space (SCS™). This offers potentially meaningful treatment benefit to patients suffering from sight threatening diseases like uveitis, retinal vein occlusion, diabetic macular edema and wet age-related macular degeneration.  To learn more about how Clearside is changing ophthalmology, please visit us at www.clearsidebio.com .

Contacts: Stephen Kilmer Investor Relations (678) 270-3631 stephen.kilmer@clearsidebio.com Charles Deignan Chief Financial Officer 678-270-4005 charlie.deignan@clearsidebio.com

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Electra Defense's $4.7M Contract Fuels USAF Innovation

Updated Category News Views 37

Electra's Latest Win: A $4.7M USAF Experiment Forget your typical aviation story, folks. Electra Defense just scored a whopping $4.7 million contract from the U.S. Air Force Research Laboratory. The goal? To push the boundaries of hybrid-electric aircraft tech, specifically their Ultra-Short Takeoff and Landing (Ultra-STOL) capabilities. This isn't about pie-in-the-sky...

Continue Reading
Trimble Unveils Bold AI Tools in Construction Push

Updated Category News Views 151

Trimble Connect's Bold Move in AI In the relentless world of construction, where risk is as common as a hard hat, Trimble's rolling out some heavy-duty AI capabilities. Today, at the annual Trimble Dimensions bash in Las Vegas, the bigwigs at Trimble (NASDAQ:TRMB) flashed their latest trick: Trimble Connect's AI arsenal. It's not just a software upgrade; it's practically...

Continue Reading
Solstice Advances Foam Agent with Eco-Friendly Twist

Updated Category News Views 51

A New Phase in Foam Blowing Agents You don’t come across a true leap in materials technology every day, and that’s exactly what's unfolding with Solstice Advanced Materials' latest venture. They’re not just talking the talk; they've hit a milestone in developing a next-gen foam blowing agent. This isn't just another tweak in a spreadsheet—it's a potential pivot in...

Continue Reading
NSAP's First Board Aims to Revolutionize Autism Care

Updated Category News Views 47

Out in Silicon Valley, where innovation isn’t just a buzzword, the National Society of Autism Professionals (NSAP) is stirring the pot with some serious leadership moves. Just this month, they cobbled together their inaugural board of directors—a gathering of eight experts from every corner of the autism field you can think of. They’re not playing small ball, no...

Continue Reading
Texas Author's Memoir Journeys Through Trauma and Growth

Updated Category News Views 101

Finding Clarity Amid Chaos When life throws the unexpected, some folks crumble, but others, like Joyce L. Skala, sift through the rubble for clarity. Her debut memoir, "There's No Such Thing as Bad," weaves through personal chaos—embracing trauma and loss like a late-night poker game where the house always wins. Born from the charred memories of her family's home...

Continue Reading
Outer Spaces Unveils OS1 at Major Energy Expo

Updated Category News Views 133

Introduction to the Future of Solar Living Just when you thought you'd seen it all, along comes Outer Spaces with their OS1—a solar pavilion and battery deck that looks at residential energy with fresh eyes. Debuting at the RE+ 2026 in Las Vegas, this isn't just another gizmo. This is about bringing solar power to your backyard without making your roof look like it...

Continue Reading
Inner City Visions Celebrates Two Decades of Impact

Updated Category News Views 72

Alfred Lomas' Transformation Fuels Lasting Change Once upon a time, Alfred Lomas was known as a brawler in the rough patches of South L.A., running with gangs and entangled in violence. But the story flipped, and instead of leaning into chaos, Lomas leaned into hope. That personal turnaround isn't just a headline—it's the crux behind Inner City Visions (ICV), the...

Continue Reading
LASEROPTEK Embraces CPT Clarity: Impacts on Dermatology

Updated Category News Views 61

CPT Changes: A New Era for Dermatology? Get this: the American Medical Association's revisions to the CPT codes could be just the spark LASEROPTEK's been waiting for. Landing on the desk is the 2027 Current Procedural Terminology (CPT) code set which clarifies how docs report targeted UVB laser treatments. We're talking about codes 96920–96922, now clear as crystal,...

Continue Reading
Foundayo Aims to Revolutionize Sleep Apnea Treatment

Updated Category News Views 81

Revolution in Sleep Health The paper has officially announced a promising shift in sleep apnea treatment. Eli Lilly's Foundayo, revealed through a Phase 3 clinical program, is looking to tackle obstructive sleep apnea (OSA) with unprecedented potential. Forget the traditional methods—this small molecule GLP-1 receptor agonist could be a game changer for folks plagued by...

Continue Reading
Chipotle's BOGO Promo Returns: Tattoos Boost Sales

Updated Category News Views 101

Chipotle's BOGO Charade: A Tattooed Affair You've got to hand it to Chipotle—they know how to turn heads and wallets with their quirky promotions. The upcoming 'Tatted Like a Chipotle Bag' offer is a prime example of how they ride the cultural zeitgeist as they gear up for another record-breaking day on Friday, November 13. And seriously, with tattoos in play, they're...

Continue Reading
reading: EZ MOUSE Revolutionizes Multi-Device Computing Control"> Continue Reading